 | • レポートコード：GIR-2104Z09971 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ニフェジピンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ニフェジピンの種類別市場規模（ニフェジピン徐放錠、ニフェジピン徐放錠）、用途別市場規模（原発性肺高血圧症、心不全、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ニフェジピンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Actavis、Teva、Pfizer、Shyndec、Honglin、Huanghai、Yabao ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ニフェジピン徐放錠、ニフェジピン徐放錠 ・用途別分析2016年-2026年：原発性肺高血圧症、心不全、その他 ・ニフェジピンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ニフェジピンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ニフェジピンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ニフェジピンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ニフェジピンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nifedipine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nifedipine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Nifedipine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nifedipine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Market segment by Application can be divided into
Primary Pulmonary Hypertension
Heart Failure
Others
The key market players for global Nifedipine market are listed below:
Bayer
Actavis
Teva
Pfizer
Shyndec
Honglin
Huanghai
Yabao
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Nifedipine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nifedipine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Nifedipine Controlled Release Tablets
1.2.3 Nifedipine Extended Action Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Nifedipine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Primary Pulmonary Hypertension
1.3.3 Heart Failure
1.3.4 Others
1.4 Global Nifedipine Market Size & Forecast
1.4.1 Global Nifedipine Sales in Value (2016-2026))
1.4.2 Global Nifedipine Sales in Volume (2016-2026)
1.4.3 Global Nifedipine Price by Type (2016-2026) & (USD/Kg)
1.5 Global Nifedipine Production Capacity Analysis
1.5.1 Global Nifedipine Total Production Capacity (2016-2026)
1.5.2 Global Nifedipine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nifedipine Market Drivers
1.6.2 Nifedipine Market Restraints
1.6.3 Nifedipine Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Nifedipine Product and Services
2.1.4 Bayer Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Actavis
2.2.1 Actavis Details
2.2.2 Actavis Major Business
2.2.3 Actavis Nifedipine Product and Services
2.2.4 Actavis Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Nifedipine Product and Services
2.3.4 Teva Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Nifedipine Product and Services
2.4.4 Pfizer Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Shyndec
2.5.1 Shyndec Details
2.5.2 Shyndec Major Business
2.5.3 Shyndec Nifedipine Product and Services
2.5.4 Shyndec Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Honglin
2.6.1 Honglin Details
2.6.2 Honglin Major Business
2.6.3 Honglin Nifedipine Product and Services
2.6.4 Honglin Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Huanghai
2.7.1 Huanghai Details
2.7.2 Huanghai Major Business
2.7.3 Huanghai Nifedipine Product and Services
2.7.4 Huanghai Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Yabao
2.8.1 Yabao Details
2.8.2 Yabao Major Business
2.8.3 Yabao Nifedipine Product and Services
2.8.4 Yabao Nifedipine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Nifedipine Sales by Manufacturer
3.1 Global Nifedipine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nifedipine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nifedipine
3.4 Market Concentration Rate
3.4.1 Top 3 Nifedipine Manufacturer Market Share
3.4.2 Top 6 Nifedipine Manufacturer Market Share
3.5 Global Nifedipine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nifedipine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nifedipine Market Size by Region
4.1.1 Global Nifedipine Sales in Volume by Region (2016-2026)
4.1.2 Global Nifedipine Revenue by Region (2016-2026)
4.2 North America Nifedipine Revenue (2016-2026)
4.3 Europe Nifedipine Revenue (2016-2026)
4.4 Asia-Pacific Nifedipine Revenue (2016-2026)
4.5 South America Nifedipine Revenue (2016-2026)
4.6 Middle East and Africa Nifedipine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nifedipine Sales in Volume by Type (2016-2026)
5.2 Global Nifedipine Revenue by Type (2016-2026)
5.3 Global Nifedipine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nifedipine Sales in Volume by Application (2016-2026)
6.2 Global Nifedipine Revenue by Application (2016-2026)
6.3 Global Nifedipine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nifedipine Sales by Type (2016-2026)
7.2 North America Nifedipine Sales by Application (2016-2026)
7.3 North America Nifedipine Market Size by Country
7.3.1 North America Nifedipine Sales in Volume by Country (2016-2026)
7.3.2 North America Nifedipine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nifedipine Sales by Type (2016-2026)
8.2 Europe Nifedipine Sales by Application (2016-2026)
8.3 Europe Nifedipine Market Size by Country
8.3.1 Europe Nifedipine Sales in Volume by Country (2016-2026)
8.3.2 Europe Nifedipine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nifedipine Sales by Type (2016-2026)
9.2 Asia-Pacific Nifedipine Sales by Application (2016-2026)
9.3 Asia-Pacific Nifedipine Market Size by Region
9.3.1 Asia-Pacific Nifedipine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nifedipine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nifedipine Sales by Type (2016-2026)
10.2 South America Nifedipine Sales by Application (2016-2026)
10.3 South America Nifedipine Market Size by Country
10.3.1 South America Nifedipine Sales in Volume by Country (2016-2026)
10.3.2 South America Nifedipine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nifedipine Sales by Type (2016-2026)
11.2 Middle East & Africa Nifedipine Sales by Application (2016-2026)
11.3 Middle East & Africa Nifedipine Market Size by Country
11.3.1 Middle East & Africa Nifedipine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nifedipine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nifedipine Typical Distributors
12.3 Nifedipine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nifedipine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nifedipine Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Nifedipine Product and Services
Table 6. Bayer Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Actavis Basic Information, Manufacturing Base and Competitors
Table 8. Actavis Major Business
Table 9. Actavis Nifedipine Product and Services
Table 10. Actavis Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Nifedipine Product and Services
Table 14. Teva Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Nifedipine Product and Services
Table 18. Pfizer Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Shyndec Basic Information, Manufacturing Base and Competitors
Table 20. Shyndec Major Business
Table 21. Shyndec Nifedipine Product and Services
Table 22. Shyndec Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Honglin Basic Information, Manufacturing Base and Competitors
Table 24. Honglin Major Business
Table 25. Honglin Nifedipine Product and Services
Table 26. Honglin Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Huanghai Basic Information, Manufacturing Base and Competitors
Table 28. Huanghai Major Business
Table 29. Huanghai Nifedipine Product and Services
Table 30. Huanghai Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Yabao Basic Information, Manufacturing Base and Competitors
Table 32. Yabao Major Business
Table 33. Yabao Nifedipine Product and Services
Table 34. Yabao Nifedipine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Nifedipine Sales by Manufacturer (2019-2021e) & (MT)
Table 36. Global Nifedipine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Nifedipine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Nifedipine Production Capacity by Company, (MT): 2020 VS 2021
Table 39. Head Office and Nifedipine Production Site of Key Manufacturer
Table 40. Global Nifedipine Sales by Region (2016-2021e) & (MT)
Table 41. Global Nifedipine Sales by Region (2021-2026) & (MT)
Table 42. Global Nifedipine Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Nifedipine Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Nifedipine Sales by Type (2016-2021e) & (MT)
Table 45. Global Nifedipine Sales by Type (2021-2026) & (MT)
Table 46. Global Nifedipine Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Nifedipine Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Nifedipine Price by Type (2016-2021e) & (USD/Kg)
Table 49. Global Nifedipine Price by Type (2021-2026) & (USD/Kg)
Table 50. Global Nifedipine Sales by Application (2016-2021e) & (MT)
Table 51. Global Nifedipine Sales by Application (2021-2026) & (MT)
Table 52. Global Nifedipine Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Nifedipine Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Nifedipine Price by Application (2016-2021e) & (USD/Kg)
Table 55. Global Nifedipine Price by Application (2021-2026) & (USD/Kg)
Table 56. North America Nifedipine Sales by Country (2016-2021e) & (MT)
Table 57. North America Nifedipine Sales by Country (2021-2026) & (MT)
Table 58. North America Nifedipine Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Nifedipine Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Nifedipine Sales by Type (2016-2021e) & (MT)
Table 61. North America Nifedipine Sales by Type (2021-2026) & (MT)
Table 62. North America Nifedipine Sales by Application (2016-2021e) & (MT)
Table 63. North America Nifedipine Sales by Application (2021-2026) & (MT)
Table 64. Europe Nifedipine Sales by Country (2016-2021e) & (MT)
Table 65. Europe Nifedipine Sales by Country (2021-2026) & (MT)
Table 66. Europe Nifedipine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Nifedipine Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Nifedipine Sales by Type (2016-2021e) & (MT)
Table 69. Europe Nifedipine Sales by Type (2021-2026) & (MT)
Table 70. Europe Nifedipine Sales by Application (2016-2021e) & (MT)
Table 71. Europe Nifedipine Sales by Application (2021-2026) & (MT)
Table 72. Asia-Pacific Nifedipine Sales by Region (2016-2021e) & (MT)
Table 73. Asia-Pacific Nifedipine Sales by Region (2021-2026) & (MT)
Table 74. Asia-Pacific Nifedipine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Nifedipine Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Nifedipine Sales by Type (2016-2021e) & (MT)
Table 77. Asia-Pacific Nifedipine Sales by Type (2021-2026) & (MT)
Table 78. Asia-Pacific Nifedipine Sales by Application (2016-2021e) & (MT)
Table 79. Asia-Pacific Nifedipine Sales by Application (2021-2026) & (MT)
Table 80. South America Nifedipine Sales by Country (2016-2021e) & (MT)
Table 81. South America Nifedipine Sales by Country (2021-2026) & (MT)
Table 82. South America Nifedipine Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Nifedipine Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Nifedipine Sales by Type (2016-2021e) & (MT)
Table 85. South America Nifedipine Sales by Type (2021-2026) & (MT)
Table 86. South America Nifedipine Sales by Application (2016-2021e) & (MT)
Table 87. South America Nifedipine Sales by Application (2021-2026) & (MT)
Table 88. Middle East & Africa Nifedipine Sales by Country (2016-2021e) & (MT)
Table 89. Middle East & Africa Nifedipine Sales by Country (2021-2026) & (MT)
Table 90. Middle East & Africa Nifedipine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Nifedipine Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Nifedipine Sales by Type (2016-2021e) & (MT)
Table 93. Middle East & Africa Nifedipine Sales by Type (2021-2026) & (MT)
Table 94. Middle East & Africa Nifedipine Sales by Application (2016-2021e) & (MT)
Table 95. Middle East & Africa Nifedipine Sales by Application (2021-2026) & (MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Nifedipine Typical Distributors
Table 99. Nifedipine Typical Customers
List of Figures
Figure 1. Nifedipine Picture
Figure 2. Global Nifedipine Sales Market Share by Type in 2020
Figure 3. Nifedipine Controlled Release Tablets
Figure 4. Nifedipine Extended Action Tablets
Figure 5. Global Nifedipine Sales Market Share by Application in 2020
Figure 6. Primary Pulmonary Hypertension
Figure 7. Heart Failure
Figure 8. Others
Figure 9. Global Nifedipine Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 10. Global Nifedipine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Nifedipine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Nifedipine Sales (2016-2026) & (MT)
Figure 31. Global Nifedipine Production Capacity (2016-2026) & (MT)
Figure 32. Global Nifedipine Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Nifedipine Market Drivers
Figure 34. Nifedipine Market Restraints
Figure 35. Nifedipine Market Trends
Figure 36. Global Nifedipine Sales Market Share by Manufacturer in 2020
Figure 37. Global Nifedipine Revenue Market Share by Manufacturer in 2020
Figure 38. Nifedipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Nifedipine Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Nifedipine Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Nifedipine Sales Market Share by Region (2016-2026)
Figure 42. Global Nifedipine Revenue Market Share by Region (2016-2026)
Figure 43. North America Nifedipine Revenue (2016-2026) & (USD Million)
Figure 44. Europe Nifedipine Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Nifedipine Revenue (2016-2026) & (USD Million)
Figure 46. South America Nifedipine Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Nifedipine Revenue (2016-2026) & (USD Million)
Figure 48. Global Nifedipine Sales Market Share by Type (2016-2026)
Figure 49. Global Nifedipine Revenue Market Share by Type (2016-2026)
Figure 50. Global Nifedipine Price by Type (2016-2026) & (USD/Kg)
Figure 51. Global Nifedipine Sales Market Share by Application (2016-2026)
Figure 52. Global Nifedipine Revenue Market Share by Application (2016-2026)
Figure 53. Global Nifedipine Price by Application (2016-2026) & (USD/Kg)
Figure 54. North America Nifedipine Sales Market Share by Country (2016-2026)
Figure 55. North America Nifedipine Revenue Market Share by Country (2016-2026)
Figure 56. North America Nifedipine Sales Market Share by Type (2016-2026)
Figure 57. North America Nifedipine Sales Market Share by Application (2016-2026)
Figure 58. Europe Nifedipine Sales Market Share by Country (2016-2026)
Figure 59. Europe Nifedipine Revenue Market Share by Country (2016-2026)
Figure 60. Europe Nifedipine Sales Market Share by Type (2016-2026)
Figure 61. Europe Nifedipine Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Nifedipine Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Nifedipine Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Nifedipine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Nifedipine Sales Market Share by Application (2016-2026)
Figure 66. South America Nifedipine Sales Market Share by Country (2016-2026)
Figure 67. South America Nifedipine Revenue Market Share by Country (2016-2026)
Figure 68. South America Nifedipine Sales Market Share by Type (2016-2026)
Figure 69. South America Nifedipine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Nifedipine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Nifedipine Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Nifedipine Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Nifedipine Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の高血圧・心不全治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypertension and Heart Failure Treatment Market The global Hypertension and Heart Failure Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- 世界の徐放性プロテイン市場 2021：企業別、地域別、種類・用途別 The Extended Release Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の肺動脈性肺高血圧症（PAH）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pulmonary Arterial Hypertension (PAH) Market The global Pulmonary Arterial Hypertension (PAH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の慢性血栓塞栓性肺高血圧症（CTEPH）市場規模・現状・予測（2021年-2027年） Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Heal…
- 世界の肺動脈性肺高血圧症治療市場規模・現状・予測（2021年-2027年） Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries re…